These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18194842)

  • 1. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
    Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
    Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.
    Jain P; Kumar P; Pai VR; Parikh PM
    Indian J Cancer; 2008; 45(3):83-9. PubMed ID: 19018109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer.
    Cho YH; Lee SH; Kim DW; Wu HG; Hah JH; Rhee CS; Sung MW; Kim KH; Heo DS
    Head Neck; 2008 Mar; 30(3):346-50. PubMed ID: 17972310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.
    Posner MR
    Oncologist; 2005; 10 Suppl 3():11-9. PubMed ID: 16368867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in head and neck cancer: should it be revisited?
    Specenier PM; Vermorken JB
    Cancer Lett; 2007 Oct; 256(2):166-77. PubMed ID: 17673364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does induction chemotherapy have a role in the management of locoregionally advanced squamous cell head and neck cancer?
    Adelstein DJ; Leblanc M
    J Clin Oncol; 2006 Jun; 24(17):2624-8. PubMed ID: 16763275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future chemotherapy and radiotherapy options in head and neck cancer.
    Merlano M; Mattiot VP
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):395-403. PubMed ID: 16503856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ preservation in multimodality therapy of head and neck cancer.
    Urba S; Wolf GT
    Hematol Oncol Clin North Am; 1991 Aug; 5(4):713-24. PubMed ID: 1890062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V; Parsons JT; Greene BD; Sharma V
    Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis.
    Su YX; Zheng JW; Zheng GS; Liao GQ; Zhang ZY
    Chin Med J (Engl); 2008 Oct; 121(19):1939-44. PubMed ID: 19080128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The present situation of neoadjuvant therapy for head and neck carcinoma].
    Rikimaru F; Tomita K
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1535-7. PubMed ID: 17940367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy in locally advanced head and neck cancer: a new standard of care?
    Lorch JH; Posner MR; Wirth LJ; Haddad RI
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1155-63, viii. PubMed ID: 19010265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary treatment of locally advanced rectal cancer: a literature review. Part 1.
    Berardi R; Maccaroni E; Onofri A; Giampieri R; Bittoni A; Pistelli M; Scartozzi M; Pierantoni C; Bianconi M; Cascinu S
    Expert Opin Pharmacother; 2009 Oct; 10(14):2245-58. PubMed ID: 19640208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy].
    Bardet E; Bourhis J; Cals L; Fayette J; Guigay J; Hans S; Saint-Guily JL; Lagarde F; Lallemant B; Milano G; Rolland F; Lefebvre JL
    Bull Cancer; 2009 Oct; 96(10):1013-28. PubMed ID: 19744919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer.
    Posner M; Vermorken JB
    Semin Oncol; 2008 Jun; 35(3):221-8. PubMed ID: 18544437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemoradiation paradigm in head and neck cancer.
    Seiwert TY; Salama JK; Vokes EE
    Nat Clin Pract Oncol; 2007 Mar; 4(3):156-71. PubMed ID: 17327856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.